These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 14962108

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P.
    J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
    [Abstract] [Full Text] [Related]

  • 4. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Kerl H, Wolf P.
    Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
    [Abstract] [Full Text] [Related]

  • 5. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.
    Stern RS, Bolshakov S, Nataraj AJ, Ananthaswamy HN.
    J Invest Dermatol; 2002 Aug; 119(2):522-6. PubMed ID: 12190879
    [Abstract] [Full Text] [Related]

  • 6. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I, Gottschling M, Krawtchenko N, Lehmann MD, Röwert-Huber J, Eberle J, Stockfleth E, Forschner T.
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [Abstract] [Full Text] [Related]

  • 7. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
    Gasparro FP, Liao B, Foley PJ, Wang XM, McNiff JM.
    Environ Mol Mutagen; 1998 May; 31(2):105-12. PubMed ID: 9544188
    [Abstract] [Full Text] [Related]

  • 8. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA, Marcil I, Stern RS.
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [Abstract] [Full Text] [Related]

  • 9. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
    Nataraj AJ, Wolf P, Cerroni L, Ananthaswamy HN.
    J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
    [Abstract] [Full Text] [Related]

  • 10. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin.
    Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwarz M.
    Cancer Res; 1992 Nov 15; 52(22):6400-3. PubMed ID: 1423288
    [Abstract] [Full Text] [Related]

  • 11. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
    Lambertini L, Surin K, Ton TV, Clayton N, Dunnick JK, Kim Y, Hong HH, Devereux TR, Sills RC.
    Toxicol Pathol; 2005 Nov 15; 33(2):292-9. PubMed ID: 15902973
    [Abstract] [Full Text] [Related]

  • 12. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA.
    Wang XM, McNiff JM, Klump V, Asgari M, Gasparro FP.
    Photochem Photobiol; 1997 Aug 15; 66(2):294-9. PubMed ID: 9277151
    [Abstract] [Full Text] [Related]

  • 13. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP.
    Am J Clin Dermatol; 2000 Aug 15; 1(6):337-48. PubMed ID: 11702610
    [Abstract] [Full Text] [Related]

  • 14. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL, Stern RS.
    J Invest Dermatol; 2005 Mar 15; 124(3):505-13. PubMed ID: 15737190
    [Abstract] [Full Text] [Related]

  • 15. Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers.
    Nataraj AJ, Black HS, Ananthaswamy HN.
    Proc Natl Acad Sci U S A; 1996 Jul 23; 93(15):7961-5. PubMed ID: 8755585
    [Abstract] [Full Text] [Related]

  • 16. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice.
    Nomura T, Nakajima H, Hongyo T, Taniguchi E, Fukuda K, Li LY, Kurooka M, Sutoh K, Hande PM, Kawaguchi T, Ueda M, Takatera H.
    Cancer Res; 1997 Jun 01; 57(11):2081-4. PubMed ID: 9187098
    [Abstract] [Full Text] [Related]

  • 17. Photoreactivation does not alter ras and p53 mutation spectra in ultraviolet radiation-induced corneal sarcomas of Monodelphis domestica.
    Kusewitt DF, Preble NE, Bonnett CD.
    Mol Carcinog; 2000 Feb 01; 27(2):117-24. PubMed ID: 10657904
    [Abstract] [Full Text] [Related]

  • 18. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice.
    van Kranen HJ, de Gruijl FR, de Vries A, Sontag Y, Wester PW, Senden HC, Rozemuller E, van Kreijl CF.
    Carcinogenesis; 1995 May 01; 16(5):1141-7. PubMed ID: 7767977
    [Abstract] [Full Text] [Related]

  • 19. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study.
    J Am Acad Dermatol; 2002 Jul 01; 47(1):33-9. PubMed ID: 12077578
    [Abstract] [Full Text] [Related]

  • 20. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas.
    Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB.
    Arch Dermatol; 1995 Jul 01; 131(7):796-800. PubMed ID: 7611795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.